AFYX THERAPEUTICS
AFYX Therapeutics is changing the way mucosal diseases are treated. They are a topical drug delivery company developing a pipeline of targeted treatments for conditions that currently lack approved therapy options. Their proprietary Rivelin® patch is flexible, biodegradable, and adhesive to mucosal surfaces. Designed with electrospinning technology, it delivers a therapeutic directly to the site in need, without interfering with patients’ daily activities.
AFYX THERAPEUTICS
Industry:
Biotechnology Clinical Trials Delivery Health Care Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.afyxtx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]@afyxtx.com
Total Funding:
30.72 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Google Font API Google Tag Manager WordPress Google Analytics Global Site Tag Organization Schema Google Universal Analytics Sitelinks Search Box
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.
Caladrius Biosciences
Caladrius Biosciences is a clinical-stage biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Destiny Pharma
Destiny Pharma Ltd., a clinical stage pharmaceutical company
Molecular Partners
Molecular Partners is a clinical-stage biopharmaceutical company.
Relief Therapeutics
Relief Therapeutics is a clinical stage biotechnology company.
SAB Biotherapeutics
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Lundbeckfonden Emerge
Lundbeckfonden Emerge investment in Debt Financing - AFYX Therapeutics
Novo Holdings
Novo Holdings investment in Debt Financing - AFYX Therapeutics
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - AFYX Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series A - AFYX Therapeutics
Lundbeckfonden Emerge
Lundbeckfonden Emerge investment in Series A - AFYX Therapeutics
Novo Holdings
Novo Holdings investment in Series A - AFYX Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2020-11-18 | AFYX Therapeutics Appoints Dennis Kim, M.D., MBA, as Chief Medical Officer |
Official Site Inspections
http://www.afyxtx.com Semrush global rank: 11.52 M Semrush visits lastest month: 156
- Host name: webcluster2.webpod17-cph3.one.com
- IP address: 46.30.215.185
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "AFYX Therapeutics"
AFYX Therapeutics
We find new indications for existing technologies.Through our research, we work relentlessly to improve lives by addressing unmet medical needs.Reversed Innovation is our core value.See details»
AFYX Therapeutics - Crunchbase Company Profile
AFYX Therapeutics is a clinical stage biopharmaceutical companyAFYX …See details»
AFYX Therapeutics A/S - LinkedIn
Having thrived in dynamic settings, Manasa’s skills in organization, multitasking, and people-first collaboration make her a perfect fit for our mission to innovate …See details»
AFYX Therapeutics AS - Drug pipelines, Patents, Clinical trials
May 8, 2025 AFYX Therapeutics is revolutionizing the treatment of mucosal diseases by developing a range of targeted therapies for conditions with limited or no approved treatment …See details»
AFYX Therapeutics A/S | DANISH BIO – DANSK BIOTEK
AFYX is based on the merger of three great and innovative companies bringing significant synergies together and thereby creating a commercial biopharmaceutical company with 3 late …See details»
Afyx Therapeutics Inc in San Diego, CA - (858) 224-0063 - Profile
This organization primarily operates in the Pharmaceutical Preparations business / industry within the Chemicals and Allied Products sector. This organization has been operating for …See details»
AFYX Therapeutics - Overview, News & Similar companies
Apr 15, 2021 View AFYX Therapeutics (www.afyxtx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
AFYX Therapeutics - 2025 Company Profile & Team - Tracxn
Jun 21, 2025 AFYX Therapeutics - Developer of drug patches for the treatment of mucosal diseases. Raised a total funding of $33.3M over 6 rounds from 8 investors.See details»
AFYX Therapeutics Company Profile | Management and Employees …
AFYX Therapeutics is a clinical stage biopharmaceutical company focused on innovative approaches to treat mucosal diseases. AFYX's lead product candidate, Rivelin-CLO patch, …See details»
Afyx Therapeutics - BioCentury Company Profiles - BCIQ
Headquarters: Copenhagen, Denmark Website: https://afyxtx.com Year Founded: 2014 Status: Private BioCentury | Apr 12, 2022 Management TracksSee details»
AFYX Therapeutics Company Profile - Office Locations ... - Craft
AFYX Therapeutics (formerly known as Dermtreat ApS) is a biopharmaceutical company focused on innovative approaches to treat mucosal diseases. Its Rivelin patch is designed to deliver a …See details»
Afyx - VentureRadar
AFYX Therapeutics is a clinical-stage biopharmaceutical company focused on innovative approaches to treat mucosal diseases. AFYX’s lead product candidate, Rivelin-CLO patch, …See details»
AFYX Therapeutics 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for AFYX Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
AFYX THERAPEUTICS INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AFYX THERAPEUTICS INC of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
AFYX Therapeutics A/S - LinkedIn
We strive for this in AFYX, while building an organization in rapid growth. We know that when we work together, the sky's the limit. Therefore, we have defined a set of core values for who we …See details»
Afyx | VentureRadar
AFYX Therapeutics is a clinical-stage biopharmaceutical company focused on innovative approaches to treat mucosal diseases. AFYX’s lead product candidate, Rivelin-CLO patch, …See details»
AFYX Therapeutics Overview | SignalHire Company Profile
AFYX Therapeutics is a private company that has been in the industry for 9 years. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. The position …See details»
AFYX Therapeutics - Financial Details - Crunchbase
AFYX Therapeutics is a clinical stage biopharmaceutical companySee details»
Afyxtx – San Diego Biotechnology Network
News Ticker [ March 30, 2023 ] Lineage and the Christopher & Dana Reeve Foundation Proudly Present the 1st Annual Spinal Cord Injury Investor Symposium News [ March 30, 2023 ] …See details»
AFYX Therapeutics - News & Analysis - Crunchbase
AFYX Therapeutics is a clinical stage biopharmaceutical companyWednesday, November 23, 2022 Google Patent Nov 23, 2022 Mucosal patches and methods of use thereof Wednesday, …See details»